Your session is about to expire
← Back to Search
This trial will test if a light-activated vitamin can safely and effectively treat an eye condition that causes new blood vessels to grow.
- Corneal Neovascularization
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- You have had an allergic reaction to the medication being used in the study.
- Group 1: 10 minute photoactivation
- Group 2: 30 minute photoactivation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What does 30 minute photoactivation therapy usually target?
"30 minute photoactivation can be used for a variety of conditions, such as vitamin deficiency, joint pain, and vitamin supplementation."
Are there any other research studies that use 30 minute photoactivation?
"As of now, there are 20 trials being run studying 30 minute photoactivation. 11 of those active studies are in Phase 3. While the majority of studies for 30 minute photoactivation are based in San Francisco, California, there are 47 locations running trials for this treatment."
How many participants will be taking part in this experiment?
"That is correct. The listing on clinicaltrials.gov makes it clear that this study is still recruiting patients. The trial was first announced on May 3rd, 2021 and was last updated on July 27th, 2022. Currently, the research team is looking for 62 individuals from a single site."
Are new participants being taken in for this experiment?
"That is correct, the listing on clinicaltrials.gov currently says that this study is open for recruitment. This specific trial was first announced on May 3rd, 2021 and was last updated on July 27th, 2022. They are 62 patients needed in total from 1 site."
Share this study with friends